Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 11.240 | ||
| Révision: | $846.50M | $911.24M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 9.070 | 13.050 | 3.9800 |
| Révision: | $796.65M | $823.45M | $163.34M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 6.460 | 6.650 | 0.1900 |
| Révision: | $745.21M | $869.77M | -$3.39M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 9.320 | 12.160 | 2.8400 |
| Révision: | $745.00M | $1.34B | $113.37M |
